Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Allegro microsystems - Caught on Camera

Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops

These three stocks are down big after earnings, but price targets rose anyway. Updated forecasts now see nearly 50% upside in two mid-cap chip stocks.

MarketBeat

Stocks Turn Lower on Stagflation Fears

The S&P 500 Index ($SPX ) (SPY ) today is down -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.16%. March E-mini S&P futures (ESH25 ) are down -0.20%, and March E-mini Nasdaq futures...

Barchart

Positive Corporate News Supports Stocks Ahead of Tuesday's Tariff News

The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. March E-mini S&P futures (ESH25 ) are up +0.05%, and March E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga

People

Donald Trump

188,409 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.